Article
Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study.
Cancer - 1 Feb 2026
Montgomery Bruce, Lynch Julie A, Brown Jessica, Maxwell Kara N, Teerlink Craig C, Kabilovic Nismeta, Stoll Katie, Simon Julie, Kogan Maria, Hassan Sajida, Whitbourne Stacey B, Muralidhar Sumitra, Schoen Martin W, Ramoni Rachel, Gaziano J Michael, Sokolova Alexandra O, Cheng Heather H, Etzioni Ruth, Pritchard Colin C
Abstract excerpt
BACKGROUND: Germline pathogenic variants can inform targeted therapy for metastatic prostate cancer (mPC), and improve cancer early detection and risk reduction for family members. Guidelines recommend germline genetic testing be offered to all men with mPC, yet uptake of testing is only 10%-12%. METHODS: This prospective study enrolled veterans participating in the VA Million Veteran Program (MVP) with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
